Amphotericin B liposomal less toxic than lipid complex formulation

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2001年 / 835卷 / 1期
关键词：
Febrile Neutropenia; Liposomal Amphotericin; Lipid Complex; Lipid Formulation; AmBisome;
D O I：
10.2165/00128415-200108350-00010
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [21] Retrospective comparison or lipid amphotericin B complex (ABLC) and liposomal amphotericin B (L-AMB) in the pediatric population.
    Sykes, RB
    Sahni, J
    Ellis, JM
    Kuti, JL
    PHARMACOTHERAPY, 2005, 25 (03): : 469 - 469
  • [22] Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States
    Yang H.
    Chaudhari P.
    Zhou Z.-Y.
    Wu E.Q.
    Patel C.
    Horn D.L.
    Applied Health Economics and Health Policy, 2014, 12 (1) : 85 - 93
  • [23] BUDGET IMPACT ANALYSIS OF LIPOSOMAL AMPHOTERICIN B AND AMPHOTERICIN B LIPID COMPLEX FOR TREATING INVASIVE FUNGAL INFECTIONS IN HOSPITALIZED PATIENTS
    Chaudhari, P.
    Yang, H.
    Zhou, Z. Y.
    Patel, C.
    Wu, E. Q.
    VALUE IN HEALTH, 2013, 16 (03) : A83 - A84
  • [24] Liposomal and lipid-based formulations of amphotericin B
    deMarie, S
    LEUKEMIA, 1996, 10 : S93 - S96
  • [25] Drug-Induced Nephrotoxicity Caused by Amphotericin B Lipid Complex and Liposomal Amphotericin B A Review and Meta-Analysis
    Safdar, Amar
    Ma, Jonathan
    Saliba, Fouzi
    Dupont, Bertrand
    Wingard, John R.
    Hachem, Ray Y.
    Mattiuzzi, Gloria N.
    Chandrasekar, Pranatharthi H.
    Kontoyiannis, Dimitrios P.
    Rolston, Kenneth V.
    Walsh, Thomas J.
    Champlin, Richard E.
    Raad, Issam I.
    MEDICINE, 2010, 89 (04) : 236 - 244
  • [26] Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach
    Liu, Huolong
    Rivnay, Benjamin
    Avery, Ken
    Myung, Ja Hye
    Kozak, Darby
    Landrau, Nelson
    Nivorozhkin, Alex
    Ashraf, Muhammad
    Yoon, Seongkyu
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 585
  • [27] Respiratory distress secondary to both amphotericin B deoxycholate and lipid complex formulation
    Rolland, WA
    Guharoy, R
    Ramirez, L
    Blair, D
    Medicis, J
    Khan, U
    VETERINARY AND HUMAN TOXICOLOGY, 2000, 42 (04) : 222 - 223
  • [28] Development of liposomal amphotericin B dry powder inhaler formulation
    Shah, SP
    Misra, A
    DRUG DELIVERY, 2004, 11 (04) : 247 - 253
  • [29] Liposomal Formulation Decreases Toxicity of Amphotericin B In Vitro and In Vivo
    Roberts, Justin
    Bingham, Josh
    McLaren, Alex C.
    McLemore, Ryan
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2015, 473 (07) : 2262 - 2269
  • [30] Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
    Ubals, Maria
    Bosch-Nicolau, Pau
    Sanchez-Montalva, Adrian
    Salvador, Fernando
    Aparicio-Espanol, Gloria
    Sulleiro, Elena
    Silgado, Aroa
    Soriano-Arandes, Antoni
    Espiau, Maria
    Ferrer, Berta
    Pou, Diana
    Trevino, Begona
    Molina, Israel
    Garcia-Patos, Vicente
    PATHOGENS, 2021, 10 (10):
12345